New Delhi, Feb 19 (PTI) Bharat Biotech on Saturday said its Covaxin will be evaluated as a COVID-19 vaccine candidate in the US. In a statement, Ocugen Inc, Bharat Biotech’s…
The U.S. recently added two new weapons to its small arsenal against the coronavirus: pills that patients can take at home to treat COVID-19. The drugs from Pfizer and Merck…
The USFDA on Thursday issued an emergency use authorization (EUA) for MSD’s Covid-19 antiviral medication molnupiravir for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults who are at high…
Biopharmaceutical major Biocon has its eyes set on the US insulin market, which is expected to grow to $29.9 billion by 2025, with its interchangeable biosimilar product Semglee that has…
The US drug regulator has asked several pharmaceutical companies to repeat the studies conducted at two Indian contract research organisations (CROs) – Synchron Research Services and Panexcell Clinical Lab –…
